Skip to main content

ScienceDex / Researcher record

Timothy An-Thy Chan

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2024 NIH rank #6,947
  • Program Leader
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

$1.7M
Full award amounts, FY2024
5
Records listing this PI
#6,947
By linked amount among FY2024 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$1,724,8065#6,947
2025$1,060,3244#15,493
2026$2,216,8362#9,268

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY2024 · selected5 records
  2. FY20254 records
  3. FY20262 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Timothy An-Thy Chan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9306964Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-9265-0283Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • OTHER BASIC SCIENCES
  • Pathology

FY2024 award records by amount

NIH award records listing Timothy An-Thy Chan as a PI. Multi-PI records show the full award amount for context.

  • 5R35CA232097-08R35Contact PI
    Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
    $961.7K
    award amount
  • 3U01CA260513-02S3U01Co-investigator
    Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
    $433.2K
    award amount
  • 5U54CA274513-03U54Contact PI
    Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
    $231.8K
    award amount
  • 3U54CA274513-03S2U54Contact PI
    Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
    $64.6K
    award amount
  • 3U54CA274513-03S1U54Contact PI
    Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
    $33.6K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Timothy An-Thy Chan as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Cleveland Clinic Lerner College of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6947
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding